Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes

President Donald Trump may not be getting the cascading drug prices he promised, but he is holding the line against any increases — at least for this year.

Novartis CEO Vas Narasimhan today joined Pfizer CEO Ian Read in promising to put the brake on US drug price hikes. And that will add to the pressure on the rest of the major players to do the same.